摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

US9833448, Example 8 from US 2010/0179166 | 1092784-12-7

中文名称
——
中文别名
——
英文名称
US9833448, Example 8 from US 2010/0179166
英文别名
N-[(6S,9R)-6-(2,3-difluorophenyl)-3-(2-hydroxypropan-2-yl)-6,7,8,9-tetrahydro-5H-imidazo[1,2-a]azepin-9-yl]-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,6'-5,7-dihydrocyclopenta[c]pyridine]-3'-carboxamide
US9833448, Example 8 from US 2010/0179166化学式
CAS
1092784-12-7
化学式
C32H30F2N6O3
mdl
——
分子量
584.625
InChiKey
IDZRBQDLAOIEQP-MOFPZTFXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    43
  • 可旋转键数:
    4
  • 环数:
    7.0
  • sp3杂化的碳原子比例:
    0.34
  • 拓扑面积:
    122
  • 氢给体数:
    3
  • 氢受体数:
    8

文献信息

  • PIPERIDINONE CARBOXAMIDE AZAINDANE CGRP RECEPTOR ANTAGONISTS
    申请人:Bell Ian M.
    公开号:US20120122899A1
    公开(公告)日:2012-05-17
    The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    本发明涉及哌啶酮羧酰胺吖啶生物,它们是CGRP受体拮抗剂,可用于治疗或预防CGRP参与的疾病,如偏头痛。该发明还涉及包含这些化合物的药物组合物,以及在预防或治疗CGRP参与的这类疾病中使用这些化合物和组合物。
  • Piperidinone carboxamide azaindane CGRP receptor antagonists
    申请人:Merck Sharp & Dohme Corp.
    公开号:EP2821407A1
    公开(公告)日:2015-01-07
    The present invention is directed to piperidinone carboxamide azaindane derivatives of formula I which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
    本发明涉及式 I 的哌啶酮羧酰胺氮杂生物,其是 CGRP 受体的拮抗剂,可用于治疗或预防 CGRP 所涉及的疾病,如偏头痛。本发明还涉及包含这些化合物的药物组合物,以及这些化合物和组合物在预防或治疗CGRP参与的此类疾病中的用途。
  • US8481556B2
    申请人:——
    公开号:US8481556B2
    公开(公告)日:2013-07-09
  • US8754096B2
    申请人:——
    公开号:US8754096B2
    公开(公告)日:2014-06-17
  • US8912210B2
    申请人:——
    公开号:US8912210B2
    公开(公告)日:2014-12-16
查看更多